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Background: Visceral (VAT) and subcutaneous (SAT) adipose tissues contribute to obesity but may differ in their metabolic and atherosclerosis risk 
profiles.
Methods: Among 1200 obese participants in the Dallas Heart Study, we examined the cross-sectional associations of abdominal VAT and SAT 
mass, assessed by MRI and indexed to body surface area (BSA), with biomarkers of insulin resistance, dyslipidemia, and inflammation; aortic plaque 
and liver fat by MRI; and coronary calcium by EBCT. Sex-stratified associations of VAT/BSA and SAT/BSA were examined after adjustment for age, 
race, menopausal status, and BMI.
Results: In multivariable models, VAT was significantly associated with HOMA-IR, lower adiponectin, smaller LDL and HDL particle size, larger VLDL 
size, and increased LDL and VLDL particle number (Table). Associations with VAT were seen for several inflammatory biomarkers, including C-reactive 
protein, but were quantitatively more modest. VAT was also associated with prevalent diabetes, metabolic syndrome, hepatic steatosis, and 
aortic plaque. In contrast, SAT was associated with leptin and several inflammatory biomarkers but not with adverse metabolic or atherosclerosis 
phenotypes.
Conclusions: VAT associates with an adverse metabolic and atherogenic phenotype whereas SAT associates with a modestly inflammatory 
but metabolically benign phenotype. These findings suggest that clinically relevant sub-phenotypes of obesity can be defined by abdominal fat 
distribution. 
Multivariable-Adjusted Linear Regression Models of Relation of VAT or SAT to Biomarkers: Standardized  coefficient of VAT or SAT
Women (n=746) Men (n=454)
Biomarker VAT/BSA SAT/BSA VAT/BSA SAT/BSA
HOMA-IR 0.32† 0.07 0.20† 0.10
Leptin -0.05 0.29† 0.18† 0.61†
Adiponectin -0.17† 0.01 -0.13* 0.11
LDL particle no. 0.20† -0.01 0.18* 0.14
LDL size -0.25† 0.07 -0.19* 0.08
VLDL particle no. 0.13* 0.02 0.21† -0.15
VLDL size 0.17† 0.003 0.13* 0.05
HDL particle no. 0.07 0.04 0.01 0.06
HDL size -0.26† 0.03 -0.13* -0.01
hs-CRP 0.28† 0.24* 0.28† 0.24*
sESAM 0.12* 0.15* 0.07 0.17*
Liver Fat (%) 0.31† 0.01 0.28† 0.13
Aortic plaque burden 0.40† 0.06 0.19* 0.07
Aortic wall thickness 0.19† -0.01 0.16* 0.03
* p<0.05; † p<0.001
Models adjusted for age + race + menopausal status (women only) + VAT/BSA + SAT/BSA + BMI
